Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc. (ITCI) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 848 transactions totaling $259.3M, demonstrating a bearish sentiment with -$159.3M in net insider flow. The most recent transaction on Aug 30, 2024 involved a transaction of 34,396 shares valued at $437.9K.
ITCI Insider Activity Summary
Who Is Buying ITCI Stock?
No significant insider buying has been recorded for ITCI in the recent period.
Who Is Selling ITCI Stock?
No significant insider selling has been recorded for ITCI in the recent period.
Is Intra-Cellular Therapies, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ITCI is bearish with an Insider Alignment Score of 19/100 and a net flow of -$159.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ITCI Frequently Asked Questions
Understanding ITCI Insider Activity
Insider trading at Intra-Cellular Therapies, Inc. (ITCI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading ITCI stock, having executed 848 transactions in the past 90 days. The most active insider is Sharon Mates (Executive), who has made 143 transactions totaling $84.1M.
Related Tools
Track Intra-Cellular Therapies, Inc. Insider Activity
Get notified when executives and directors at ITCI file new Form 4 transactions